BAX|Analyst Targets
BAX|Company Info
BAX|Insider Trading
BAX|Fundamentals
BAX|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.52 | - | - |
| Q2'26 | $0.37 | $0.56 | +52.2% |
| Q1'26 | $0.31 | $0.36 | +15.7% |
| Q4'25 | $0.33 | $0.44 | +34.0% |
| Q3'25 | $0.60 | $0.69 | +15.4% |
| Q2'25 | $0.61 | $0.54 | -11.5% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.9B | - | - |
| Q2'26 | $2.8B | $3.0B | +4.9% |
| Q1'26 | $2.6B | $2.7B | +2.1% |
| Q4'25 | $2.6B | $3.0B | +14.2% |
| Q3'25 | - | $2.8B | - |
| Q2'25 | - | $2.8B | - |
BAX|Monthly Returns
Market Data
BAX Stock Snapshot
- Market cap
- 12.86B
- Day range
- $24.58 – $25.04
- News sentiment
- 37/100 · Bearish
- Analyst target
- $27.92 (+12.6%)
- Consensus
- Hold · 21 analysts
BAX is in a holding pattern - neither trend nor momentum has taken control. In Healthcare, names this size usually take direction from sector flows before company-level news.
Reverse DCF
What growth is priced into BAX?
At today's price, Baxter International Inc. needs to grow free cash flow about 3.8% a year for the next 10 years to justify its valuation at a 6.85% cost of capital. Over its actual history it has compounded free cash flow at -6.4% a year, so the market is asking for 10.2 percentage points above its own delivered rate. On that basis BAX looks priced above what its own growth record supports.
- Implied FCF growth
- 3.8%
- Historical FCF CAGR
- -6.4%
- Growth gap
- +10.2 pts
- Verdict
- RICH
- Discount rate (WACC)
- 6.85%
- Beta
- 0.93
Behaviour On Record
What BAX's own history says about today's numbers
- Realized volatility (21d)
- 23.5% 56th pct
- Below its peak
- -73.6%
- vs 200-day average
- +18.8%
- Up days (1y)
- 49%
Baxter International Inc. is currently running 23.5% annualised volatility over the last 21 sessions. Measured against BAX's own 13 years of daily returns rather than a market-wide average, that is the 56th percentile — close to its own typical level, against a typical reading of 22.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
BAX is trading -73.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -22.0%, and the deepest was -52.1% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +18.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 97th percentile — a wider gap than this stock usually carries. Over the past year BAX closed higher on 49% of sessions, and it is currently 5 sessions into a rising streak.
On October specifically: over 14 years of records, BAX finished the month higher 4 of 14 times, with a median return of -2.5% and an average of -4.1%. Its strongest month historically has been April at +2.3% on average, its weakest October at -4.1%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: BAX has opened more than 2% away from the prior close in 93 of 3,268 sessions (2.8% of the time), with the largest gaps running +5.4% and -5.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, BAX moved an average of 2.0% in the session after earnings, closing higher 1 of those 3 times, with a median move of -0.4% and a largest of +4.5%.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against BAX's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of BAX's sector?
Baxter International Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on BAX?
Barclays most recently initiated coverage on Baxter International Inc. to Underweight on Oct 7, 2026 with a price target of $20. Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- Barclays — Underweight
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1
Peers & ETF holders
BAX peers & ETF holders
Medical Instruments & SuppliesMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | ▲ Buy | 81,842,105 | 15.91% | $1.74B | 2026-08-07 |
| Vanguard Group Inc | ▲ Buy | 62,635,136 | 12.17% | $1.20B | 2026-01-29 |
| FMR LLC (Fidelity) | ▲ Buy | 53,913,831 | 10.48% | $1.15B | 2026-08-13 |
| Geode Capital Management, LLC | ▲ Buy | 14,123,689 | 2.75% | $300.59M | 2026-08-12 |
| Invesco Ltd. | ▼ Sell | 12,361,881 | 2.40% | $263.56M | 2026-08-14 |
| Goldman Sachs Group Inc | ▲ Buy | 7,150,462 | 1.39% | $152.45M | 2026-08-14 |
| Morgan Stanley | ▼ Sell | 6,359,790 | 1.24% | $135.59M | 2026-08-13 |
| Bank of America Corp | ▲ Buy | 6,237,950 | 1.21% | $132.99M | 2026-08-14 |
| Northern Trust Corp | ▲ Buy | 4,864,004 | 0.95% | $103.70M | 2026-08-13 |
| Marshall Wace, LLP | ▲ Buy | 4,857,267 | 0.94% | $103.56M | 2026-08-13 |
| Norges Bank | ▼ Sell | 4,144,905 | 0.81% | $88.37M | 2026-08-12 |
| JPMorgan Chase & Co | ▼ Sell | 2,364,139 | 0.46% | $52.58M | 2026-08-12 |
| AQR Capital Management LLC | ▲ Buy | 1,936,013 | 0.38% | $41.28M | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 1,029,431 | 0.20% | $21.95M | 2026-08-14 |
| Artisan Partners Limited Partnership | ▼ Sell | 1,023,677 | 0.20% | $21.82M | 2026-08-13 |
| Gotham Asset Management, LLC | ▲ Buy | 862,123 | 0.17% | $18.38M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 667,731 | 0.13% | $14.24M | 2026-08-03 |
| Verition Fund Management LLC | ▲ Buy | 464,280 | 0.09% | $9.90M | 2026-08-14 |
| AllianceBernstein L.P. | ▲ Buy | 557,680 | 0.11% | $9.37M | 2026-08-14 |
| Susquehanna International Group, LLP | ▼ Sell | 381,553 | 0.07% | $8.13M | 2026-08-14 |
| Adage Capital Partners GP, L.L.C. | ▼ Sell | 288,347 | 0.06% | $6.15M | 2026-08-14 |
| Man Group plc | ▲ Buy | 271,465 | 0.05% | $5.79M | 2026-08-14 |
| Prudential Financial Inc | ▼ Sell | 245,449 | 0.05% | $5.23M | 2026-08-12 |
| Neuberger Berman Group LLC | ▼ Sell | 245,401 | 0.05% | $5.23M | 2026-08-13 |
| Citadel Advisors LLC | ▼ Sell | 222,747 | 0.04% | $4.75M | 2026-09-02 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-31 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-10-30 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-30 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-09-25 | 2025-10-22 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-08-04 | 2025-09-12 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-07-22 | 2025-08-13 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-05-15 | 2025-06-09 |
| Dan Sullivan | Senate | AK | ▼ Sell | $1K - $15K | 2022-11-30 | 2023-07-26 |